Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Aug 11, 2016 · 10-Q · 42 days after period end · 0001193125-16-679305
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Revenue | $1.07M | $160.24K | $698.23K |
| Net Income | -$5.88M | -$3.53M | -$2.88M |
| EPS Diluted | -$0.14 | -$0.12 | -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 11, 2016 · 42 d after period end
